Role of Toll-like receptors in liver health and disease (Q37907346)

25 August 2017

1 reference

title

Role of Toll-like receptors in liver health and disease (English)

1 reference

25 August 2017

0 references

1 reference

Ruth Broering

1

1 reference

25 August 2017

Mengji Lu

series ordinal

2

1 reference

25 August 2017

Joerg F Schlaak

series ordinal

3

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 November 2011

1 reference

25 August 2017

1 reference

25 August 2017

121

1 reference

25 August 2017

10

1 reference

25 August 2017

415-426

1 reference

The instructive role of innate immunity in the acquired immune response

25 August 2017

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Pathogen recognition and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Toll-like receptors in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Local control of the immune response in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Hepatic allograft-derived Kupffer cells regulate T cell response in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Characterization of the innate immune signalling pathways in hepatocyte cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

TLRs antiviral effect on hepatitis B virus in HepG2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Lipopolysaccharide-induced innate immune responses in primary hepatocytes downregulates woodchuck hepatitis virus replication via interferon-independent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoaggression against hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Toll like receptors and acute allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Toll-like receptors in the pathogenesis of alcoholic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Alcohol and oxidative liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Oxidants and antioxidants in alcohol-induced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Toll-like receptors and their role in gastrointestinal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

TLR4 enhances TGF-beta signaling and hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Loss of NF-kappaB activation in Kupffer cell-depleted mice impairs liver regeneration after partial hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Toll-like receptor signaling in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

The immune response during hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Toll-Like Receptor 3 Mediates Establishment of an Antiviral State against Hepatitis C Virus in Hepatoma Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Complete replication of hepatitis C virus in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Robust hepatitis C virus infection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Activation of anti-hepatitis C virus responses via Toll-like receptor 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Cell activation by synthetic lipopeptides of the hepatitis C virus (HCV)--core protein is mediated by toll like receptors (TLRs) 2 and 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Expression of Toll-like receptors in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Viral and Host Factors Induce Macrophage Activation and Loss of Toll-Like Receptor Tolerance in Chronic HCV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Fascination with 2-5A-dependent RNase: a unique enzyme that functions in interferon action

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Viral stress-inducible protein p56 inhibits translation by blocking the interaction of eIF3 with the ternary complex eIF2.GTP.Met-tRNAi

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Induction and mode of action of the viral stress-inducible murine proteins, P56 and P54.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

ISG15: the immunological kin of ubiquitin

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20110065

21 January 2018

Identifiers

DOI

10.1042/CS20110065

1 reference

25 August 2017

1 reference